Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials
✍ Scribed by C. Jaulerry; J. Rodriguez; F. Brunin; M. Jouve; V. Mosseri; D. Point; D. Pontvert; P. Validire; B. Zafrani; B. Blaszka; B. Asselain; P. Pouillart; J. Brugère
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 829 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
stage 11-Ill-IV squamous cell carcinoma of the oropharynx or oral cavity were randomized to induction chemotherapy, consisting of bleomycin (10 mg/m\*/day in continuous infusion from day 1 to day 5), methotrexate (120 mg/m2 on day 2) followed by folink acid, 5-fluorouracil (5 FU) (600 mg/m2 on day 2
A four-drug combination chemotherapy (bleomycin-methotrexate-vinblastine-CCNU) had been used in 38 evaluable patients with recurrent squamous cell carcinoma of the head and neck region on an outpatient basis. A large number of these patients had carcinoma of the oral cavity (45% of total). Nineteen